Table 3.
Author | Year | Age | Sex | A-Fib/Flutter | EF | U/S | BB | Pressor | ECMO | IMPELA | TPE | ECMO Decannulation | HLS | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abubakr et al. | 2017 | 39 | M | Yes | 15-20% | LVF | Y | Y | N | N | Y | - | 11 | Expired |
Eyadiel et al. | 2018 | 27 | F | No | <10% | LVF | Y | Y | Y | Y | Y | 6 d | - | Live |
Allencherril et al. | 2015 | 29 | M | Yes | <20% | LVF | Y | Y | Y | N | N | 7 d | - | Live |
NGO et al. | 2007 | 32 | M | Yes | 25% | LVF | Y | Y | N | N | N | - | 9 | Live |
28 | M | Yes | 20% | LVF | Y | Y | N | N | N | - | 9 | Expired | ||
Kim et al. | 2018 | 52 | M | Yes | <20% | LVF | Y | Y | Y | N | N | 6 d | 14 | Live |
Dahl et al. | 2008 | 32 | F | No | - | - | Y | - | N | N | N | - | - | Live |
Chao et al. | 2015 | 47 | M | - | 24% (20-24) | LVF | N | Y | Y | N | N | 3.4 d | - | Expired |
43 | M | - | Expired | |||||||||||
37 | F | - | Live | |||||||||||
42 | M | - | Live | |||||||||||
33 | F | - | Live | |||||||||||
Kiriyama et al. | 2017 | 54 | F | Yes | <20% | LVF | N | N | Y | N | N | 18 d | 18 | Live |
White et al. | 2018 | 57 | F | Yes | <10% | LVF | N | Y | Y | N | N | 10 d | 53 | Live |
Koball et al. | 2010 | 68 | F | - | - | - | Y | Y | N | N | Y | - | 18 | Live |
Hsu et al. | 2011 | 47 | M | Yes | 32% | LVF | N | Y | Y | N | N | - | 5 | Expired |
43 | M | No | 20% | 5 d | 20 | Live | ||||||||
37 | F | Yes | 32% | 5 d | 5 | Live | ||||||||
42 | M | No | 29% | 5 d | 5 | Live | ||||||||
Palkar et al. | 2012 | 27 | F | No | 40% | LVF | Y | - | N | N | N | - | - | Live |